Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Thromb Haemost. 2018 Aug 9;16(9):1743–1752. doi: 10.1111/jth.14235

Table 4:

Association of eGFR and incident VTE with adjustment for biomarkers of procoagulation and inflammation

Model HR (95% CI) of VTE per 10-unit lower eGFR HR (95% CI) of VTE by quartile of eGFR (ml/min/1.73m2)

Q1 (7-≤71) Q2 (>71-≤87) Q3 (>87-≤103) Q4 (>103–107)
Case-Cohort Study

Cases (n) 66 74 60 47
Cohort sample (n) 233 225 239 252
Base Model* 1.13 (1.02, 1.25) 1.39 (0.77, 2.49) 1.19 (0.71, 2.01) 1.06 (0.65, 1.74) 1.0
Base Model + D-dimer 1.10 (0.99, 1.21) 1.12 (0.62, 2.05) 1.11 (0.65, 1.91) 1.06 (0.64, 1.76) 1.0
Base Model + FVIII 0.98 (0.87, 1.11) 0.69 (0.35, 1.37) 0.60 (0.32, 1.11) 0.86 (0.50, 1.48) 1.0
Base Model + CRP 1.11 (1.00, 1.22) 1.24 (0.68, 2.24) 1.15 (0.69, 1.94) 1.03 (0.63, 1.69) 1.0

Full Cohort
Base Model 1.09 (1.02, 1.16) 1.46 (0.91, 2.36) 1.13 (0.72, 1.80) 0.97 (0.61, 1.54) 1.0
Base Model + CRP 1.07 (1.00, 1.15) 1.36 (0.84, 2.19) 1.09 (0.69, 1.72) 0.96 (0.60, 1.52) 1.0

Abbreviations: HR, hazard ratio; CI, confidence interval; Q, quartile; FVIII, Factor VIII; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate. eGFR as a predictor is presented as a continuous variable (HR per 10 ml/min/1.73m2 decrement) and as quartiles with reference group as the highest quartile of eGFR. Cox models were adjusted for age, sex, race, region, race*region and BMI (Base Model*) and biomarkers individually. D-dimer and CRP were log transformed.